The role of variants regulating metformin transport and action in women with polycystic ovary syndrome (Q30275579)

14 June 2017

The role of variants regulating metformin transport and action in women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

14 June 2017

1 reference

1 reference

1 reference

Cindy T Pau

1

1 reference

14 June 2017

Kai I Cheang

2

1 reference

14 June 2017

Bhavi P Modi

3

1 reference

14 June 2017

Thushiga Kasippillai

4

1 reference

14 June 2017

Candace C Keefe

5

1 reference

14 June 2017

Maria Shulleeta

6

1 reference

14 June 2017

William S Evans

7

1 reference

14 June 2017

Lubna Pal

8

1 reference

14 June 2017

Jerome F Strauss

9

1 reference

14 June 2017

John E Nestler

10

1 reference

14 June 2017

Corrine K Welt

11

1 reference

14 June 2017

28 October 2016

1 reference

14 June 2017

1 reference

Insulin resistance in nonobese patients with polycystic ovarian disease

14 June 2017

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Effects of short-term and long-term metformin treatment on menstrual cyclicity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Responsiveness to metformin in girls with androgen excess: collective influence of genetic polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin-induced lactic acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

A gene-gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Pharmacogenetic variation and metformin response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

release_fbe2lgx7wjdpvhcrbwvanaknti

21 January 2018

Identifiers

DOI

10.2217/PGS-2016-0079

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fbe2lgx7wjdpvhcrbwvanaknti

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference